SCHEMBL3846829

SCHEMBL3846829

COC(=O)c1nn(C(c2ccccc2)(c2ccccc2)c2ccccc2)cc1Br

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.44
MAPT P10636 5/20 0.43
KDM4E B2RXH2 3/20 0.43
SMN1; SMN2 Q16637 4/20 0.41
ALDH1A1 P00352 3/20 0.41
TP53 P04637 2/20 0.41
NPC1 O15118 1/20 0.41
ALOX15 P16050 1/20 0.41
MAPK1 P28482 1/20 0.41
RAB9A P51151 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ELANE P08246 2/20 0.41
F2 P00734 1/20 0.40
PLAU P00749 1/20 0.40
KCNN4 O15554 1/20 0.38
TSHR P16473 2/20 0.38
RECQL P46063 1/20 0.37
CYP2C9 P11712 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4285291 0.83 TP53 (0.44) GAAMAPTKDM4ESMN1; SMN2ALDH1A1
SCHEMBL28916239 0.83 MAPT (0.43) GAAMAPTKDM4ESMN1; SMN2ALDH1A1
SCHEMBL28916204 0.82 KDM4E (0.42) GAAMAPTKDM4ESMN1; SMN2ALDH1A1
SCHEMBL4284526 0.80 KDM4E (0.42) GAAMAPTKDM4ESMN1; SMN2ALDH1A1
SCHEMBL17646915 0.79 NPSR1 (0.39) GAAMAPTKDM4ESMN1; SMN2ALDH1A1
SCHEMBL3848071 0.79 ALDH1A1 (0.46) GAAMAPTKDM4ESMN1; SMN2ALDH1A1
SCHEMBL3846831 0.76 GAA (0.34) GAAMAPTKDM4ESMN1; SMN2ALDH1A1
SCHEMBL3893167 0.76 SLC6A3 (0.52) MAPTKDM4EALDH1A1MEN1KMT2A
SCHEMBL3848554 0.75 LIPE (0.37) GAAMAPTKDM4ESMN1; SMN2ALDH1A1
SCHEMBL5353528 0.75 MAPT (0.43) GAAMAPTKDM4EALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed